PTYLTD
    • Insights
    • Videos
  • Pricing
  • About us
  • Contact us
  • Login | Sign up
PTYLTD

Insights

Videos

Pricing

About us

Contact us

PTYLTD

Proactive Equities

Empowering investors with insights, analysis and expert recommendations to navigate financial markets with confidence.

Open a Free Basic Account Now to Start Receiving Timely High-Conviction Investment Ideas and Actionable Trade Signals Designed To Help You Stay Ahead, and also See Our Complete History of Past Investment and Trading Results.

Kingsgate Consolidated (ASX: KCN)
Special Report

Kingsgate Consolidated (ASX: KCN): One of the Most Undervalued ASX Gold Producers

Revenue and EPS are expected to grow through FY27–FY28, although earnings remain sensitive to gold prices and mining costs. Based on FY26 normalised EPS of A$0.76 and a 10–12x P/E, fair value is estimated at A$7.6–9.1 per share.

P
Proactive Equities Team
high-conviction ASX income stocks for 2026
Special Report

Our 3 high-conviction ASX income stocks for 2026

This report highlights three high-yield ASX dividend stocks across different industries, offering strong income and upside potential over the next 6–12 months, backed by durable competitive advantages, profitable business models, and valuations that appear attractive relative to their long-term growth prospects.

P
Proactive Equities Team
Our high-conviction gold opportunity for 2026
Special Report

Our high-conviction gold opportunity for 2026

This ASX gold producer is undervalued due to limited production history, but strong early margins suggest significant profit potential and a possible near-term re-rating. It operates a low-risk open-pit mine with long reserves, resources, and added silver by-product exposure.

P
Proactive Equities Team

Editor's Picks

Dateline Resources (ASX: DTR)

Dateline Resources (ASX: DTR): Colosseum’s Gold Reserves Offer Significant Upside, but Legal and Development Risks Remain

Dateline Resources (ASX: DTR) holds 100% of Colosseum, with a 573,000oz gold reserve and A$86.0 million cash. An August 2026 court injunction halted activities, creating legal and financing risks. Colosseum is valued at US$380 million to US$727 million.

Oct 21, 2026 | Proactive Equities Team

Recent Articles

SomnoMed (ASX: SOM)

SomnoMed (ASX: SOM): Jumps 23% From Yearly Low as Europe Reset Tests Growth Story

Oct 21, 2026 | Proactive Equities Team

Overwatch Technologies (ASX: OWL)

Overwatch Technologies (ASX: OWL): IPO Puts Maritime Surveillance Growth Prospects in Focus

Oct 21, 2026 | Proactive Equities Team

Gulf Stream Energy (ASX: GSE)

Gulf Stream Energy (ASX: GSE): Directors Put Fresh Cash behind Oil Push

Oct 21, 2026 | Proactive Equities Team

Black Canyon (ASX: BCA)

Black Canyon (ASX: BCA): Option Expiry and AGM Put Capital Structure in Focus

Oct 21, 2026 | Proactive Equities Team

Alterity Therapeutics (ASX: ATH)

Alterity Therapeutics (ASX: ATH): New ATH434 Analysis Strengthens Case for Phase 3 Development

Oct 21, 2026 | Proactive Equities Team

RemSense Technologies (ASX: REM)

RemSense Technologies (ASX: REM): Director Options Plan Puts Pay and Dilution in Focus

Oct 21, 2026 | Proactive Equities Team

Dateline Resources (ASX: DTR)

Dateline Resources (ASX: DTR): Colosseum’s Gold Reserves Offer Significant Upside, but Legal and Development Risks Remain

Oct 21, 2026 | Proactive Equities Team

Norwood Systems (ASX: NOR)

Norwood Systems (ASX: NOR): Driving Next-Gen Voice AI Solutions with Oversubscribed Note Financing

Oct 20, 2026 | Proactive Equities Team

Starpharma Holdings (ASX: SPL)

Starpharma Holdings (ASX: SPL): Petalion Stake Increase Puts Oncology Pipeline in Focus

Oct 20, 2026 | Proactive Equities Team

Adisyn (ASX: AI1)

Adisyn (ASX: AI1): 10 Million Performance Rights Hand New Graphene Chief a Revenue Test

Oct 20, 2026 | Proactive Equities Team

Insights from Technical Analysis
SomnoMed (ASX: SOM)

SomnoMed (ASX: SOM): Jumps 23% From Yearly Low as Europe Reset Tests Growth Story

Oct 21, 2026
Proactive Equities Team

SomnoMed (ASX: SOM) shares jumped 23% to $0.29 near their yearly low, as the sleep apnoea device maker weighs a European reimbursement reset against North American growth and wider margins after FY26 EBITDA rose 19%.

Overwatch Technologies (ASX: OWL)

Overwatch Technologies (ASX: OWL): IPO Puts Maritime Surveillance Growth Prospects in Focus

Oct 21, 2026
Proactive Equities Team

Overwatch Technologies (ASX: OWL) has raised A$8 million through its IPO to advance its maritime surveillance technology, with future growth depending on government contracts, commercialisation and its ability to convert early customer activity into sustained revenue.

Gulf Stream Energy (ASX: GSE)

Gulf Stream Energy (ASX: GSE): Directors Put Fresh Cash behind Oil Push

Oct 21, 2026
Proactive Equities Team

Gulf Stream Energy (ASX: GSE) directors Eduardo Robaina, Joseph Graham and Troy Warrick converted performance rights and joined the October placement at $0.0045, buying roughly 15.9 million shares as the small explorer reports US oil discoveries.

Black Canyon (ASX: BCA)

Black Canyon (ASX: BCA): Option Expiry and AGM Put Capital Structure in Focus

Oct 21, 2026
Proactive Equities Team

Black Canyon (ASX: BCA) has issued new shares following option exercises, recorded the expiry of unexercised options, and outlined key resolutions for its November AGM, including a proposed 10% placement capacity to fund Wandanya Project development.

Alterity Therapeutics (ASX: ATH)

Alterity Therapeutics (ASX: ATH): New ATH434 Analysis Strengthens Case for Phase 3 Development

Oct 21, 2026
Proactive Equities Team

Alterity Therapeutics (ASX: ATH) reported an adjusted Phase 2 analysis showing ATH434 slowed functional decline by about 52% versus placebo at Week 52, as the company advances Phase 3 planning and evaluates funding needs.

RemSense Technologies (ASX: REM)

RemSense Technologies (ASX: REM): Director Options Plan Puts Pay and Dilution in Focus

Oct 21, 2026
Proactive Equities Team

RemSense Technologies (ASX: REM) will ask shareholders to approve 45 million unlisted options for its three directors at its 30 October AGM, a move that would dilute existing holders by about 15.6% if fully exercised, alongside an auditor appointment.

Dateline Resources (ASX: DTR)

Dateline Resources (ASX: DTR): Colosseum’s Gold Reserves Offer Significant Upside, but Legal and Development Risks Remain

Oct 21, 2026
Proactive Equities Team

Dateline Resources (ASX: DTR) holds 100% of Colosseum, with a 573,000oz gold reserve and A$86.0 million cash. An August 2026 court injunction halted activities, creating legal and financing risks. Colosseum is valued at US$380 million to US$727 million.

Norwood Systems (ASX: NOR)

Norwood Systems (ASX: NOR): Driving Next-Gen Voice AI Solutions with Oversubscribed Note Financing

Oct 20, 2026
Proactive Equities Team

Norwood Systems (ASX: NOR) raised $695,000 through an oversubscribed convertible note as its OpenSpan Voice AI pilots with Tier-1 telecom operators advance, after FY26 revenue rose 22% to $2.32 million.

Starpharma Holdings (ASX: SPL)

Starpharma Holdings (ASX: SPL): Petalion Stake Increase Puts Oncology Pipeline in Focus

Oct 20, 2026
Proactive Equities Team

Starpharma Holdings (ASX: SPL) has increased its stake in Petalion Therapeutics to 66%, gaining majority ownership of its FAP-targeted oncology program and allocating up to A$5 million to advance drug development and support future partnering opportunities.

Adisyn (ASX: AI1)

Adisyn (ASX: AI1): 10 Million Performance Rights Hand New Graphene Chief a Revenue Test

Oct 20, 2026
Proactive Equities Team

Adisyn (ASX: AI1) has appointed former Tower Semiconductor COO Ephraim Koltin to lead its graphene subsidiary, with up to 10 million performance rights tied to customer contracts, revenue and share price hurdles that will define how commercial progress is judged.

Dividend Stocks Insights
Woodside Energy (ASX: WDS)

Woodside Energy (ASX: WDS): Growth Projects, Dividend Strength and Valuation Outlook

Oct 20, 2026
Proactive Equities Team

Woodside Energy (ASX: WDS) lifted 1H2026 net profit 27% to US$1.67bn and declared a US57 cent interim dividend. Scarborough LNG is 98% complete, with first cargo targeted for Q4 2026. Valuation is A$27.28 to A$32.24.

Flight Centre Travel Group (ASX: FLT)

Flight Centre (ASX: FLT): Earnings Recovery and Buy-backs Support Upside, but Travel-Sector Risks Remain

Oct 20, 2026
Proactive Equities Team

Flight Centre’s FY2026 revenue reached A$2.86 billion and net profit A$149 million. Corporate growth and buybacks support recovery, while leisure weakness and geopolitical risks persist. Forecast earnings underpin a valuation range of A$14.88–A$17.36 per share.

Challenger (ASX: CGF)

Challenger (ASX: CGF): Daiichi's $11.80 Offer Tests Value of Australia's Retirement Income Leader

Oct 19, 2026
Proactive Equities Team

Challenger (ASX: CGF) has received a non-binding $11.80 per share takeover proposal from Daiichi Life's Australian arm, arriving alongside record annuity sales, a new funding program and a pending Fidante merger shaping the group's future.

South32 (ASX: S32)

South32 (ASX: S32): Portfolio Transformation, Copper and Zinc Growth, and Valuation Outlook

Oct 16, 2026
Proactive Equities Team

South32 is reshaping its portfolio by proposing to sell an aluminium asset, prioritising growth in copper and zinc. Stronger earnings and the Sierra Gorda and Hermosa developments support its outlook, while rising costs, execution risks and commodity volatility remain key considerations.

Domino’s Pizza Enterprises (ASX: DMP)

Domino’s Pizza Enterprises (ASX: DMP): Leadership Shake-Up Puts Reset Plan in Focus

Oct 14, 2026
Proactive Equities Team

Domino’s Pizza Enterprises (ASX: DMP) has placed Australia and New Zealand operations under direct Group CEO oversight, renewed its Belgium franchise agreement and temporarily extended its France agreement as it works to advance its Reset Plan.

CSL (ASX: CSL)

CSL (ASX: CSL): US$1.5 Billion Bond Deal and Plasma Tech Switch Shape Its Turnaround

Oct 14, 2026
Proactive Equities Team

CSL (ASX: CSL) has priced US$1.5 billion of corporate bonds to refinance debt and confirmed a Haemonetics plasma technology rollout across US centres by 2027, two moves that shape its recovery after a heavy reset year.

Vitura Health (ASX: VIT)

Vitura Health (ASX: VIT): $685,000 Cost Cut Puts Profit Plan on Firmer Ground

Oct 13, 2026
Proactive Equities Team

Vitura Health (ASX: VIT) beat its own first-quarter expectations, with revenue up 4.8%, EBITDA lifted and operating costs cut. Management's Three Horizon Plan targets profitability, with more detail due at the November annual general meeting.

Telstra Group (ASX: TLS)

Telstra Group (ASX: TLS): Borrowing Abroad Is Powering the Company Buy-Back Machine

Oct 12, 2026
Proactive Equities Team

Telstra Group (ASX: TLS) has sought ASX quotation for a NOK 2 billion bond while its A$1 billion buy-back gathers pace, signalling a deliberate shift toward debt funding as it backs network and fibre investment.

Transurban Group (ASX: TCL)

Transurban Group (ASX: TCL): $4.5b Sydney Toll Road Deal Locks in Control without New Equity

Oct 2, 2026
Proactive Equities Team

Transurban (ASX: TCL) has agreed to buy Canada Pension Plan Investment Board's Sydney toll road stakes for $4.5 billion in cash, lifting control of WestConnex, Westlink M7 and NorthConnex without raising equity.

Ampol (ASX: ALD)

Ampol (ASX: ALD): $225m Evie Deal Plugs Fuel Giant into Australia's Electric Future

Oct 2, 2026
Proactive Equities Team

Ampol (ASX: ALD) will buy Evie Networks for $225 million, creating Australia's largest public EV fast-charging network by bays. The debt-funded deal targets $30 million-plus earnings within three years, pending ACCC clearance.

Stock Market News and More
Macroeconomic Report Ending 18 October 2026

Macroeconomic Report for the Week Ending 18 October 2026 – Australian Market Outlook

Oct 19, 2026
Proactive Equities Team

Global markets weighed persistent inflation, uneven growth, and geopolitical risks. Australian shares gained 1.03%, led by Utilities, Health Care, and Consumer Staples, while weaker employment, RBA rate expectations, commodity prices, and China’s trade outlook shaped investor sentiment.

Capital Raisings Explained

Capital Raisings Explained: Placements, SPPs and Rights Issues

Oct 12, 2026
Proactive Equities Team

Learn how capital raisings work in the Australian share market, including placements, Share Purchase Plans (SPPs) and rights issues. Understand how each method affects existing shareholders, what share dilution means, and what to consider before participating.

Macroeconomic Report Ending 11 October 2026

Macroeconomic Report for the Week Ending 11 October 2026 – Australian Market Outlook

Oct 12, 2026
Proactive Equities Team

Global markets faced inflation risks, elevated bond yields, and geopolitical uncertainty. Australian shares posted modest gains led by Utilities, Energy, and Consumer Staples, while weaker consumer sentiment, RBA rate expectations, commodity prices, and AI investment shaped the domestic outlook.

Compound Interest Calculator

Compound Interest Calculator: Shows How Patient Savers Let Time Do the Heavy Lifting

Oct 9, 2026
Proactive Equities Team

Moneysmart’s compound interest calculator shows how earning interest on interest lifts savings, super and investments, and why starting early, even with modest deposits, can make a big difference to a balance over the long run.

Options and Warrants on the ASX

Options and Warrants on the ASX: A Beginner's Guide to Risk and Reward

Oct 7, 2026
Proactive Equities Team

Options and warrants can magnify gains and losses on ASX shares. This beginner's guide explains how each works, how they differ, which types exist, and the risks every new investor should understand first.

ASX Index Rebalances Explained

ASX Index Rebalances Explained: Why Stocks Move and Who Gets in Faster Now?

Oct 6, 2026
Proactive Equities Team

ASX index rebalances can move share prices as funds buy additions and sell deletions. New three-month rules and a lower free float hurdle also make entry quicker.

CGT on Australian Shares

CGT on Australian Shares: A Guide to Capital Gains Tax

Oct 6, 2026
Proactive Equities Team

Learn how Capital Gains Tax (CGT) applies to Australian shares, including capital gains and losses, the 50% CGT discount, dividends, wash sale rules, and proposed changes that could affect investors from 2027.

Macroeconomic Report Ending  4 October 2026

Macroeconomic Report for the Week Ending 4 October 2026 – Australian Market Outlook

Oct 6, 2026
Proactive Equities Team

Global markets remained sensitive to persistent inflation, elevated energy prices, and shifting interest-rate expectations. Australian shares rebounded as the RBA raised rates to 4.60%, while commodity prices, Chinese demand, trade data and cautious consumer spending shaped the domestic market outlook.

Dividend Dates Simplified

Dividend Dates Simplified: Ex-Dividend, Record, Payment and Declaration Explained

Oct 5, 2026
Proactive Equities Team

Missing the ex-dividend date can cost investors an entire payout. Here is how ex-dividend, record, payment and declaration dates work on the ASX, plus the franking credit rules worth knowing.

ETFs vs Individual Stocks

ETFs vs Individual Stocks: Which Is Better for ASX Investors?

Oct 5, 2026
Proactive Equities Team

Compare ETFs and individual ASX stocks across diversification, risk, potential returns, costs, dividends, and investment control. Learn how each approach works and which factors can help investors choose a strategy that suits their goals and risk tolerance.

Get access to Proactive Equities’ latest high conviction stock picks and trade signals

Our Standard Membership will give you access to

Our Dividend Portfolio

Our Growth Portfolio

High Conviction Buys Now

Sector Reports

Fortnightly Investor webinars

Weekly Macro Insights

We deliver regular updates with buy, hold, and sell recommendations for stocks in our Dividend and Growth portfolios, as well as for new additions to our portfolios.
Our recommendations feature attractive buy ranges, stop-loss levels, and price targets

Our Premium Membership will give you access to:

Short-term Trading Signals

Our Dividend Portfolio

Our Growth Portfolio

High Conviction Buys Now

Sector Reports

Fortnightly Investor webinars

Weekly Macro Insights

Our Premium Membership will give you access to: Everything offered in Standard Membership, plus “short-term trade signals via email and text message

Proactive Equities

At Proactive Equities, we combine deep market expertise with rigorous analysis to deliver stock recommendations you can trust. Our team of seasoned analysts continuously monitor global markets, economic trends, and company fundamentals to identify high-potential investment and trade opportunities.

Company

Home
Pricing
Contact Us
About Us

Resources

ASX Insights
Investing Basics
Videos

Links

Privacy Policy
Terms and Conditions
Product Disclosure Statement

Proactive Equities Pty Ltd (ACN: 687 232 471) is a Corporate Authorised Representative (AFSR No. 001318293) of Australia National Investment Group Pty Ltd (ABN: 40 636 343 630), which holds an Australian Financial Services Licence (AFSL no. 522028). The information on this website is general information only and does not constitute personal financial advice. We have not taken the individual circumstances, financial objectives or needs of any investor into account when preparing this information. Investors should consider their circumstances and the relevant PDS for any investment and obtain professional financial and tax advice before making any investment decision. The information on this website is not a recommendation to make any investment or to adopt any particular investment strategy. You should make your own professional assessment of the suitability of this information, relying on your own inquiries. Investments in securities are subject to investment risk. Investment value may go down as wellas up, and investors may not get back the full amount originally invested. Risks include: the investment objective may not be achieved, share market and other market risk, liquidity risk, and currency risk with international investments. Any past performance shown is not an indication of future performance. Commission and other costs charged by executing broker are not considered when calculating past performance. To the extent permitted by law Proactive Equities Pty Ltd accepts no liability for any errors or omissions in, or loss from reliance on the information in this website.